Metrics
- Impact factor
- 6.9+1.4 Clarivate JCR
- WoS quartile
- Q1 Clarivate JCR, best category
- SJR
- 1.28Q1 SCImago
- h-index
- 27
- CAS tier
- Tier 2 Chinese Academy of Sciences
- Citations per paper
- 7.83 last 2 years
- Articles per year
- 211
- Self-citation
- 1.8%
- Fee (APC), est.
- $3,337 estimated, check the journal
About this journal
- ISSN
- 2190-393X (print) · 2190-3948 (online)
- Publisher
- Springer US · Springer Nature
- Country
- Germany · Northern America
- Indexed in
- SCIE
- Access
- Hybrid · 39.3% gold OA
- Founded
- 2011
- Frequency
- 12 issues per year
- Original research
- 80.5%
- Subject areas
- Pharmacology, Toxicology and Pharmaceutics
- Categories
- Medicine, Research & Experimentalpharmacol, Pharmacology & Pharmacy
- Common topics
- Biology, Medicine, Chemistry, Organic chemistry, Materials science
Similar journals
- Q1WoS
Nature Reviews Drug Discovery
Impact factor 91.2h-index 289SJR 32.58 - Q1WoS
Advanced Drug Delivery Reviews
Impact factor 21h-index 278SJR 4.01 - Q1WoS
Journal of Medicinal Chemistry
Impact factor 7.3h-index 240SJR 1.73 - Q1WoS
Pain
Impact factor 5.8h-index 238SJR 2.13 - Q1WoS
Journal of Controlled Release
Impact factor 12.4h-index 237SJR 2.54 - Q1WoS
Antimicrobial Agents and Chemotherapy
Impact factor 4.2h-index 232SJR 1.47
Figures as of the last import; ranks are a guide, not a verdict. Back to all journals